| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Molecular Pathology, Institute of Pathology, University of Würzburg, Würzburg, Germany;
Institute of Pathology, University of Erlangen-Nürnberg, Erlangen, Germany; and
Biomedical Research and Study Center, University of Latvia, Riga, Latvia
The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms. This is due to alternative splice/polyadenylation events that lead to the predominant synthesis of two long isoforms in naive T cells and a shorter NF-ATc isoform in effector T cells. Whereas the previously described isoform NF-ATc/A contains a relatively short C terminus, the longer isoforms, B and C, span extra C-terminal peptides of 128 and 246 aa, respectively. We show here that in addition to the strong N-terminal trans-activation domain, TAD-A, which is common to all three NF-ATc isoforms, NF-ATc/C contains a second trans-activation domain, TAD-B, in its C-terminal peptide. Various stimuli of T cells that induce the activity of TAD-A also enhance the activity of TAD-B, but, unlike TAD-A, TAD-B remains unphosphorylated by protein from 12-O-tetradecanoyl 12-phorbol 13-acetate-stimulated T cells. The shorter C-terminal peptide of isoform NF-ATc/B exerts a suppressive transcriptional effect. These properties of NF-ATc/B and -C might be of importance for gene regulation in naive T lymphocytes in which NF-ATc/B and -C are predominantly synthesized.
This article has been cited by other articles:
|
|
 |
|
  M. Bourajjaj, A.-S. Armand, P. A. da Costa Martins, B. Weijts, R. van der Nagel, S. Heeneman, X. H. Wehrens, and L. J. De Windt NFATc2 Is a Necessary Mediator of Calcineurin-dependent Cardiac Hypertrophy and Heart Failure J. Biol. Chem., August 8, 2008; 283(32): 22295 - 22303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Akimzhanov, L. Krenacs, T. Schlegel, S. Klein-Hessling, E. Bagdi, E. Stelkovics, E. Kondo, S. Chuvpilo, P. Wilke, A. Avots, et al. Epigenetic Changes and Suppression of the Nuclear Factor of Activated T Cell 1 (NFATC1) Promoter in Human Lymphomas with Defects in Immunoreceptor Signaling Am. J. Pathol., January 1, 2008; 172(1): 215 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Serfling, F. Berberich-Siebelt, and A. Avots NFAT in Lymphocytes: A Factor for All Events? Sci. Signal., August 7, 2007; 2007(398): pe42 - pe42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. I. Nurieva, S. Chuvpilo, E. D. Wieder, K. B. Elkon, R. Locksley, E. Serfling, and C. Dong A Costimulation-Initiated Signaling Pathway Regulates NFATc1 Transcription in T Lymphocytes J. Immunol., July 15, 2007; 179(2): 1096 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Dienz, S. M. Eaton, T. J. Krahl, S. Diehl, C. Charland, J. Dodge, S. L. Swain, R. C. Budd, L. Haynes, and M. Rincon Accumulation of NFAT mediates IL-2 expression in memory, but not naive, CD4+ T cells PNAS, April 24, 2007; 104(17): 7175 - 7180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ryzhov, A. E. Goldstein, I. Biaggioni, and I. Feoktistov Cross-Talk between Gs- and Gq-Coupled Pathways in Regulation of Interleukin-4 by A2B Adenosine Receptors in Human Mast Cells Mol. Pharmacol., August 1, 2006; 70(2): 727 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Z. Glud, A. B. Sorensen, M. Andrulis, B. Wang, E. Kondo, R. Jessen, L. Krenacs, E. Stelkovics, M. Wabl, E. Serfling, et al. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus Blood, November 15, 2005; 106(10): 3546 - 3552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Diehl, T. Krahl, L. Rinaldi, R. Norton, C. G. Irvin, and M. Rincon Inhibition of NFAT Specifically in T Cells Prevents Allergic Pulmonary Inflammation J. Immunol., March 15, 2004; 172(6): 3597 - 3603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Hock and M. A. Brown Nuclear Factor of Activated T Cells 2 Transactivation in Mast Cells: A NOVEL ISOFORM-SPECIFIC TRANSACTIVATION DOMAIN CONFERS UNIQUE Fc{epsilon}RI RESPONSIVENESS J. Biol. Chem., July 11, 2003; 278(29): 26695 - 26703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. van Rooij, P. A. Doevendans, C. C. de Theije, F. A. Babiker, J. D. Molkentin, and L. J. De Windt Requirement of Nuclear Factor of Activated T-cells in Calcineurin-mediated Cardiomyocyte Hypertrophy J. Biol. Chem., December 6, 2002; 277(50): 48617 - 48626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Sheridan, E. K. Heist, C. R. Beals, G. R. Crabtree, and P. Gardner Protein Kinase A Negatively Modulates the Nuclear Accumulation of NF-ATc1 by Priming for Subsequent Phosphorylation by Glycogen Synthase Kinase-3 J. Biol. Chem., December 6, 2002; 277(50): 48664 - 48676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Zhou, R. Q. Cron, B. Wu, A. Genin, Z. Wang, S. Liu, P. Robson, and H. S. Baldwin Regulation of the Murine Nfatc1 Gene by NFATc2 J. Biol. Chem., March 15, 2002; 277(12): 10704 - 10711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Keen, L. Sholl, M. Wills-Karp, and S. N. Georas Preferential Activation of Nuclear Factor of Activated T Cells c Correlates with Mouse Strain Susceptibility to Allergic Responses and Interleukin-4 Gene Expression Am. J. Respir. Cell Mol. Biol., January 1, 2001; 24(1): 58 - 65. [Abstract] [Full Text]
|
|
|
|
 |
|
 C.-W. Chow, C. Dong, R. A. Flavell, and R. J. Davis c-Jun NH2-Terminal Kinase Inhibits Targeting of the Protein Phosphatase Calcineurin to NFATc1 Mol. Cell. Biol., July 15, 2000; 20(14): 5227 - 5234. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
